Alvotech (NASDAQ: ALVO, or the “Company”), a global biotech company specializing in the development and manufacture of ...

REYKJAVIK, Iceland, March 27, 2025 (GLOBE NEWSWIRE) -- Alvotech (NASDAQ: ALVO, or the “Company”), a global biotech company specializing in the development and manufacture of biosimilar ...

Josh Canavan, PharmD, RazorMetrics, and Chris O'Dell, Turquoise Health, predict pharmacy benefit managers (PBMs) will evolve toward value-based care, mirroring the broader shift toward open-cost ...

SprintRay, a leader in dental 3D printing, announces a new application programming interface (API) integration with Align Technology's iTerotm intraoral scanners. The direct integration between ...

If you want to stay updated on the latest options trades for Teva Pharmaceutical Indus, Benzinga Pro gives you real-time options trades alerts.

The global prefilled syringes market share is projected to grow from US$ 6.69 Billion in 2022 to US$ 15.0 Billion by 2030, driven by the increasing p ...

Biosimilars offer affordable medical treatments, but regulatory guidelines need updating to ensure safety, efficacy, and ...

A settlement between Amgen and Fresenius Kabi will permit the biosimilar to launch in mid-2025 in the U.S. The FDA has approved two new denosumab biosimilars that are interchangeable with the ...

The biosimilar will launch in the United States in June 2025 as part of a global settlement with Amgen, which manufactures the reference product. The higher dosage of denosumab-bnht (Bomyntra ...

In this episode presented by DIA, BioSpace's head of insights Lori Ellis discusses the evolution of women's inclusion in ...

A Sanofi subsidiary has claimed FDA approval for the first biosimilar of Novo Nordisk's Novolog, an older formulation of the Danish pharma's blockbuster insulin analogue product insulin aspart.